Carmustine-induced phosphatidylserine translocation in the erythrocyte membrane

Toxins

Volumn 5, Issue 4, 2013, Pages 703-716

  Jilani, Kashif ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Calcium; Carmustine; Cell volume; Eryptosis; Phosphatidylserine

Indexed keywords

CALCIUM ION; CARMUSTINE; HEMOGLOBIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOSOL; ERYPTOSIS; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; EXTRACELLULAR CALCIUM; HEMOLYSIS; HUMAN; HUMAN CELL;

ANEMIA, HEMOLYTIC; ANNEXIN A5; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BIOLOGICAL TRANSPORT; BLOOD BANKS; CALCIUM SIGNALING; CARMUSTINE; CELL SIZE; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMANS; INDICATORS AND REAGENTS; OSMOLAR CONCENTRATION; PHOSPHATIDYLSERINES; SURFACE PROPERTIES;

EID: 84877270091     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins5040703     Document Type: Article

References (93)

1. Lin, S.H.; Kleinberg, L.R. Carmustine wafers: Localized delivery of chemotherapeutic agents in cns malignancies. Expert Rev. Anticancer Ther. 2008, 8, 343-359.
2. El-Sayed el, S.M.; Abdel-Aziz, A.A.; Helal, G.K.; Saleh, S.; Saad, A.S. Protective effect of n-acetylcysteine against carmustine-induced myelotoxicity in rats. Food Chem. Toxicol. 2010, 48, 1576-1580.
3. Ferreri, A.J.; Bruno Ventre, M.; Donadoni, G.; Cattaneo, C.; Fumagalli, L.; Foppoli, M.; Mappa, S.; Govi, S.; di Nicola, M.; Rossi, G.; et al. Safety and activity of a new intensive short-term chemoimmunotherapy in hiv-positive patients with burkitt lymphoma. Br. J. Haematol. 2012, 159, 252-255.
4. Geisler, C.H.; Kolstad, A.; Laurell, A.; Jerkeman, M.; Raty, R.; Andersen, N.S.; Pedersen, L.B.; Eriksson, M.; Nordstrom, M.; Kimby, E.; et al. Nordic mcl2 trial update: Six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by beam or beac + autologous stem-cell support: Still very long survival but late relapses do occur. Br. J. Haematol. 2012, 158, 355-362.
5. Moore, S.; Kayani, I.; Peggs, K.; Qian, W.; Lowry, L.; Thomson, K.; Linch, D.C.; Ardeshna, K. Mini-beam is effective as a bridge to transplantation in patients with refractory or relapsed hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory dlbcl. Br. J. Haematol. 2012, 157, 543-552.
6. Wondergem, M.J.; Zijlstra, J.M.; de Rooij, M.; Visser, O.J.; Huijgens, P.C.; Zweegman, S. Improving survival in patients with transformed b cell non hodgkin lymphoma: Consolidation with (9)(0)yttrium ibritumomab tiuxetan-beam and autologous stem cell transplantation. Br. J. Haematol. 2012, 157, 395-397.
7. Linch, D.C.; Yung, L.; Smith, P.; Maclennan, K.; Jack, A.; Hancock, B.; Cunningham, D.; Hoskin, P.; Qian, W.; Holte, H.; et al. Final analysis of the uklg ly02 trial comparing 6-8 cycles of chop with 3 cycles of chop followed by a beam autograft in patients <65 years with poor prognosis histologically aggressive nhl. Br. J. Haematol. 2010, 149, 237-243.
8. Thamilselvan, V.; Menon, M.; Thamilselvan, S. Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells. Cancer Manag. Res. 2012, 4, 383-395.
9. Van Meter, T.E.; Broaddus, W.C.; Cash, D.; Fillmore, H. Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating akt activity in gliomas. Cancer 2006, 107, 2446-2454.
10. Yamauchi, T.; Ogawa, M.; Ueda, T. Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance. Mol. Pharmacol. 2008, 74, 82-91.
11. Papait, R.; Magrassi, L.; Rigamonti, D.; Cattaneo, E. Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells. Biochem. Biophys. Res. Commun. 2009, 379, 434-439.
12. El-Sayed el, S.M.; Abdel-Aziz, A.A.; Saleh, S.; Saad, A.S. The chemopreventive effect of dimethylthiourea against carmustine-induced myelotoxicity in rats. Food Chem. Toxicol. 2011, 49, 1965-1969.
13. 2+ in pc12 cells. Eur. J. Pharmacol. 2004, 497, 17-24.
14. 2+ homeostasis in cultured aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H493-H506.
15. Doroshenko, N.; Doroshenko, P. Ion dependence of cytotoxicity of carmustine against pc12 cells. Eur. J. Pharmacol. 2003, 476, 185-191.
16. Lang, F.; Gulbins, E.; Lerche, H.; Huber, S.M.; Kempe, D.S.; Föller, M. Eryptosis, a window to systemic disease. Cell Physiol. Biochem. 2008, 22, 373-380.
17. Foller, M.; Mahmud, H.; Qadri, S.M.; Gu, S.; Braun, M.; Bobbala, D.; Hocher, B.; Lang, F. Endothelin b receptor stimulation inhibits suicidal erythrocyte death. FASEB J. 2010, 24, 3351-3359.
18. 2+ leak of human erythrocytes. Cell Physiol. Biochem. 2008, 21, 183-192.
19. Foller, M.; Sopjani, M.; Koka, S.; Gu, S.; Mahmud, H.; Wang, K.; Floride, E.; Schleicher, E.; Schulz, E.; Munzel, T.; et al. Regulation of erythrocyte survival by amp-activated protein kinase. FASEB J. 2009, 23, 1072-1080.
20. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest. 1993, 92, 520-526. 21.
21. + channels in human erythrocyte apoptosis. Am. J. Physiol. Cell Physiol. 2003, 285, C1553-C1560.
22. Berg, C.P.; Engels, I.H.; Rothbart, A.; Lauber, K.; Renz, A.; Schlosser, S.F.; Schulze-Osthoff, K.; Wesselborg, S. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ. 2001, 8, 1197-1206.
23. Lang, F.; Gulbins, E.; Lang, P.A.; Zappulla, D.; Foller, M. Ceramide in suicidal death of erythrocytes. Cell Physiol. Biochem. 2010, 26, 21-28.
24. Klarl, B.A.; Lang, P.A.; Kempe, D.S.; Niemoeller, O.M.; Akel, A.; Sobiesiak, M.; Eisele, K.; Podolski, M.; Huber, S.M.; Wieder, T.; et al. Protein kinase c mediates erythrocyte "programmed cell death" following glucose depletion. Am. J. Physiol. Cell Physiol. 2006, 290, C244-C253.
25. Bhavsar, S.K.; Bobbala, D.; Xuan, N.T.; Foller, M.; Lang, F. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell Physiol. Biochem. 2010, 26, 859-868.
26. Foller, M.; Huber, S.M.; Lang, F. Erythrocyte programmed cell death. IUBMB Life 2008, 60, 661-668.
27. Foller, M.; Mahmud, H.; Gu, S.; Wang, K.; Floride, E.; Kucherenko, Y.; Luik, S.; Laufer, S.; Lang, F. Participation of leukotriene c(4) in the regulation of suicidal erythrocyte death. J. Physiol. Pharmacol. 2009, 60, 135-143.
28. Lau, I.P.; Chen, H.; Wang, J.; Ong, H.C.; Leung, K.C.; Ho, H.P.; Kong, S.K. In vitro effect of ctab- and peg-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2011, 6, 847-856.
29. Maellaro, E.; Leoncini, S.; Moretti, D.; del Bello, B.; Tanganelli, I.; de Felice, C.; Ciccoli, L. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol. 2011, doi:10.1007/s00592-011-0274-0
30. Foller, M.; Feil, S.; Ghoreschi, K.; Koka, S.; Gerling, A.; Thunemann, M.; Hofmann, F.; Schuler, B.; Vogel, J.; Pichler, B.; et al. Anemia and splenomegaly in cgki-deficient mice. Proc. Natl. Acad. Sci. USA 2008, 105, 6771-6776.
31. Bhavsar, S.K.; Gu, S.; Bobbala, D.; Lang, F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol. Biochem. 2011, 27, 547-556.
32. Kucherenko, Y.; Zelenak, C.; Eberhard, M.; Qadri, S.M.; Lang, F. Effect of casein kinase 1alpha activator pyrvinium pamoate on erythrocyte ion channels. Cell Physiol. Biochem. 2012, 30, 407-417.
33. Zelenak, C.; Eberhard, M.; Jilani, K.; Qadri, S.M.; Macek, B.; Lang, F. Protein kinase ck1alpha regulates erythrocyte survival. Cell Physiol. Biochem. 2012, 29, 171-180.
34. Gatidis, S.; Zelenak, C.; Fajol, A.; Lang, E.; Jilani, K.; Michael, D.; Qadri, S.M.; Lang, F. P38 mapk activation and function following osmotic shock of erythrocytes. Cell Physiol. Biochem. 2011, 28, 1279-1286.
35. Zelenak, C.; Foller, M.; Velic, A.; Krug, K.; Qadri, S.M.; Viollet, B.; Lang, F.; Macek, B. Proteome analysis of erythrocytes lacking amp-activated protein kinase reveals a role of pak2 kinase in eryptosis. J. Proteome Res. 2011, 10, 1690-1697.
36. Lupescu, A.; Shaik, N.; Jilani, K.; Zelenak, C.; Lang, E.; Pasham, V.; Zbidah, M.; Plate, A.; Bitzer, M.; Foller, M.; et al. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: An in vivo and in vitro study. Cell Physiol. Biochem. 2012, 30, 876-888.
37. Shaik, N.; Lupescu, A.; Lang, F. Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol. Biochem. 2012, 30, 512-522.
38. Abed, M.; Towhid, S.T.; Mia, S.; Pakladok, T.; Alesutan, I.; Borst, O.; Gawaz, M.; Gulbins, E.; Lang, F. Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am. J. Physiol. Cell Physiol. 2012, 303, C991-C999.
39. Abed, M.; Towhid, S.T.; Shaik, N.; Lang, F. Stimulation of suicidal death of erythrocytes by rifampicin. Toxicology 2012, 302, 123-128.
40. Bottger, E.; Multhoff, G.; Kun, J.F.; Esen, M. Plasmodium falciparum-infected erythrocytes induce granzyme b by nk cells through expression of host-hsp70. PLoS One 2012, 7, e33774.
41. Felder, K.M.; Hoelzle, K.; Ritzmann, M.; Kilchling, T.; Schiele, D.; Heinritzi, K.; Groebel, K.; Hoelzle, L.E. Hemotrophic mycoplasmas induce programmed cell death in red blood cells. Cell Physiol. Biochem. 2011, 27, 557-564.
42. Firat, U.; Kaya, S.; Cim, A.; Buyukbayram, H.; Gokalp, O.; Dal, M.S.; Tamer, M.N. Increased caspase-3 immunoreactivity of erythrocytes in stz diabetic rats. Exp. Diabetes Res. 2012, 2012, 316384.
43. Ganesan, S.; Chaurasiya, N.D.; Sahu, R.; Walker, L.A.; Tekwani, B.L. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: Evaluation of eryptotic pathway. Toxicology 2012, 294, 54-60.
44. 2+ rise and membrane permeabilization. Arch. Toxicol. 2012, 86, 741-752.
45. Ghashghaeinia, M.; Cluitmans, J.C.; Akel, A.; Dreischer, P.; Toulany, M.; Koberle, M.; Skabytska, Y.; Saki, M.; Biedermann, T.; Duszenko, M.; et al. The impact of erythrocyte age on eryptosis. Br. J. Haematol. 2012, 157, 606-614.
46. Ghashghaeinia, M.; Toulany, M.; Saki, M.; Bobbala, D.; Fehrenbacher, B.; Rupec, R.; Rodemann, H.P.; Ghoreschi, K.; Rocken, M.; Schaller, M.; et al. The nfkb pathway inhibitors bay 11-7082 and parthenolide induce programmed cell death in anucleated erythrocytes. Cell Physiol. Biochem. 2011, 27, 45-54.
47. Jilani, K.; Lupescu, A.; Zbidah, M.; Abed, M.; Shaik, N.; Lang, F. Enhanced apoptotic death of erythrocytes induced by the mycotoxin ochratoxin a. Kidney Blood Press Res. 2012, 36, 107-118.
48. 2+ entry, ceramide formation and suicidal death of erythrocytes. Toxicol in Vitro 2012, 27, 52-58.
49. Kucherenko, Y.V.; Lang, F. Inhibitory effect of furosemide on non-selective voltage-independent cation channels in human erythrocytes. Cell Physiol. Biochem. 2012, 30, 863-875.
50. Lang, E.; Jilani, K.; Zelenak, C.; Pasham, V.; Bobbala, D.; Qadri, S.M.; Lang, F. Stimulation of suicidal erythrocyte death by benzethonium. Cell Physiol. Biochem. 2011, 28, 347-354.
51. Lang, E.; Qadri, S.M.; Jilani, K.; Zelenak, C.; Lupescu, A.; Schleicher, E.; Lang, F. Carbon monoxide-sensitive apoptotic death of erythrocytes. Basic Clin. Pharmacol. Toxicol. 2012, 111, 348-355.
52. Lang, F.; Qadri, S.M. Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif. 2012, 33, 125-130.
53. 2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin. J. Nat. Prod. 2012, 75, 1956-1961.
54. Lupescu, A.; Jilani, K.; Zbidah, M.; Lang, F. Induction of apoptotic erythrocyte death by rotenone. Toxicology 2012, 300, 132-137.
55. Lupescu, A.; Jilani, K.; Zelenak, C.; Zbidah, M.; Qadri, S.M.; Lang, F. Hexavalent chromium-induced erythrocyte membrane phospholipid asymmetry. Biometals 2012, 25, 309-318.
56. Polak-Jonkisz, D.; Purzyc, L. Ca influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif. 2012, 34, 209-210.
57. Qadri, S.M.; Bauer, J.; Zelenak, C.; Mahmud, H.; Kucherenko, Y.; Lee, S.H.; Ferlinz, K.; Lang, F. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell Physiol. Biochem. 2011, 28, 339-346.
58. Qadri, S.M.; Kucherenko, Y.; Lang, F. Beauvericin induced erythrocyte cell membrane scrambling. Toxicology 2011, 283, 24-31.
59. 2+-permeable cation channels triggering erythrocyte cell membrane scrambling. Cell Physiol. Biochem. 2011, 28, 857-864.
60. 2+ entry and suicidal erythrocyte death by naringin. Cell Physiol. Biochem. 2012, 30, 678-686.
61. 2+ entry and suicidal erythrocyte death by naringin. Cell Physiol. Biochem. 2012, 30, 678-686.
62. Vota, D.M.; Maltaneri, R.E.; Wenker, S.D.; Nesse, A.B.; Vittori, D.C. Differential erythropoietin action upon cells induced to eryptosis by different agents. Cell Biochem. Biophys. 2012, 65, 145-157.
63. 2+ dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 2012, 51, 51-56.
64. 2 increases? J. Cardiometab. Syndr. 2008, 3, 30-34.
65. Zbidah, M.; Lupescu, A.; Jilani, K.; Lang, F. Stimulation of suicidal erythrocyte death by fumagillin. Basic Clin. Pharmacol. Toxicol. 2012, doi:10.1111/bcpt.12033
66. Zbidah, M.; Lupescu, A.; Shaik, N.; Lang, F. Gossypol-induced suicidal erythrocyte death. Toxicology 2012, 302, 101-1055.
67. Zelenak, C.; Pasham, V.; Jilani, K.; Tripodi, P.M.; Rosaclerio, L.; Pathare, G.; Lupescu, A.; Faggio, C.; Qadri, S.M.; Lang, F. Tanshinone iia stimulates erythrocyte phosphatidylserine exposure. Cell Physiol. Biochem. 2012, 30, 282-294.
68. Lang, E.; Qadri, S.M.; Lang, F. Killing me softly-Suicidal erythrocyte death. Int. J. Biochem. Cell Biol. 2012, 44, 1236-1243.
69. Calderon-Salinas, J.V.; Munoz-Reyes, E.G.; Guerrero-Romero, J.F.; Rodriguez-Moran, M.; Bracho-Riquelme, R.L.; Carrera-Gracia, M.A.; Quintanar-Escorza, M.A. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol. Cell Biochem. 2011, 357, 171-179.
70. Nicolay, J.P.; Schneider, J.; Niemoeller, O.M.; Artunc, F.; Portero-Otin, M.; Haik, G., Jr.; Thornalley, P.J.; Schleicher, E.; Wieder, T.; Lang, F. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol. Biochem. 2006, 18, 223-232.
71. Myssina, S.; Huber, S.M.; Birka, C.; Lang, P.A.; Lang, K.S.; Friedrich, B.; Risler, T.; Wieder, T.; Lang, F. Inhibition of erythrocyte cation channels by erythropoietin. J. Am. Soc. Nephrol. 2003, 14, 2750-2757.
72. Lang, P.A.; Beringer, O.; Nicolay, J.P.; Amon, O.; Kempe, D.S.; Hermle, T.; Attanasio, P.; Akel, A.; Schafer, R.; Friedrich, B.; et al. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J. Mol. Med. 2006, 84, 378-388.
73. Kempe, D.S.; Akel, A.; Lang, P.A.; Hermle, T.; Biswas, R.; Muresanu, J.; Friedrich, B.; Dreischer, P.; Wolz, C.; Schumacher, U.; et al. Suicidal erythrocyte death in sepsis. J. Mol. Med. 2007, 85, 269-277.
74. Bobbala, D.; Alesutan, I.; Foller, M.; Huber, S.M.; Lang, F. Effect of anandamide in plasmodium berghei-infected mice. Cell Physiol. Biochem. 2010, 26, 355-362.
75. Foller, M.; Bobbala, D.; Koka, S.; Huber, S.M.; Gulbins, E.; Lang, F. Suicide for survival-Death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol. Biochem. 2009, 24, 133-140.
76. Koka, S.; Bobbala, D.; Lang, C.; Boini, K.M.; Huber, S.M.; Lang, F. Influence of paclitaxel on parasitemia and survival of plasmodium berghei infected mice. Cell Physiol. Biochem. 2009, 23, 191-198.
77. Lang, P.A.; Schenck, M.; Nicolay, J.P.; Becker, J.U.; Kempe, D.S.; Lupescu, A.; Koka, S.; Eisele, K.; Klarl, B.A.; Rubben, H.; et al. Liver cell death and anemia in wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 2007, 13, 164-170.
78. Siraskar, B.; Ballal, A.; Bobbala, D.; Foller, M.; Lang, F. Effect of amphotericin b on parasitemia and survival of plasmodium berghei-infected mice. Cell Physiol. Biochem. 2010, 26, 347-354.
79. Lang, P.A.; Kasinathan, R.S.; Brand, V.B.; Duranton, C.; Lang, C.; Koka, S.; Shumilina, E.; Kempe, D.S.; Tanneur, V.; Akel, A.; et al. Accelerated clearance of plasmodium-infected erythrocytes in sickle cell trait and annexin-a7 deficiency. Cell Physiol. Biochem. 2009, 24, 415-428.
80. Kempe, D.S.; Lang, P.A.; Duranton, C.; Akel, A.; Lang, K.S.; Huber, S.M.; Wieder, T.; Lang, F. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J. 2006, 20, 368-370.
81. Qadri, S.M.; Mahmud, H.; Lang, E.; Gu, S.; Bobbala, D.; Zelenak, C.; Jilani, K.; Siegfried, A.; Foller, M.; Lang, F. Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J. Cell Mol. Med. 2012, 16, 1085-1093.
82. Birka, C.; Lang, P.A.; Kempe, D.S.; Hoefling, L.; Tanneur, V.; Duranton, C.; Nammi, S.; Henke, G.; Myssina, S.; Krikov, M.; et al. Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch. 2004, 448, 471-477.
83. Wong, K.H.; Wallen, C.A.; Wheeler, K.T. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) in rats bearing unclamped and clamped 9l subcutaneous tumors. Int. J. Radiat. Oncol. Biol. Phys. 1989, 17, 135-143.
84. Bookchin, R.M.; Ortiz, O.E.; Lew, V.L. Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog. Clin. Biol. Res. 1987, 240, 193-200.
85. Brand, V.B.; Sandu, C.D.; Duranton, C.; Tanneur, V.; Lang, K.S.; Huber, S.M.; Lang, F. Dependence of plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol. Biochem. 2003, 13, 347-356.
86. Borst, O.; Abed, M.; Alesutan, I.; Towhid, S.T.; Qadri, S.M.; Foller, M.; Gawaz, M.; Lang, F. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via cxcl16/sr-psox. Am. J. Physiol. Cell Physiol. 2012, 302, C644-C651.
87. Andrews, D.A.; Low, P.S. Role of red blood cells in thrombosis. Curr. Opin. Hematol. 1999, 6, 76-82.
88. Closse, C.; Dachary-Prigent, J.; Boisseau, M.R. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br. J. Haematol. 1999, 107, 300-302.
89. Gallagher, P.G.; Chang, S.H.; Rettig, M.P.; Neely, J.E.; Hillery, C.A.; Smith, B.D.; Low, P.S. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003, 101, 4625-4627.
90. Pandolfi, A.; di Pietro, N.; Sirolli, V.; Giardinelli, A.; di Silvestre, S.; Amoroso, L.; di Tomo, P.; Capani, F.; Consoli, A.; Bonomini, M. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J. Cell Physiol. 2007, 213, 699-709.
91. Wood, B.L.; Gibson, D.F.; Tait, J.F. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical associations. Blood 1996, 88, 1873-1880.
92. Chung, S.M.; Bae, O.N.; Lim, K.M.; Noh, J.Y.; Lee, M.Y.; Jung, Y.S.; Chung, J.H. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb. Vasc. Biol. 2007, 27, 414-421.
93. Zwaal, R.F.; Comfurius, P.; Bevers, E.M. Surface exposure of phosphatidylserine in pathological cells. Cell Mol. Life Sci. 2005, 62, 971-988.